58754-96-4 Usage
Description
N-(2,2-DiMethoxyethyl)-4-Methyl-N-(thiophen-3-ylMethyl)benzenesulfonaMide is an organic compound that serves as an intermediate in the synthesis of various chemical compounds, particularly those with antimicrobial properties. It is characterized by its unique molecular structure, which includes a benzene ring, a thiophene ring, and a sulfonamide group, among other functional groups.
Uses
Used in Pharmaceutical Industry:
N-(2,2-DiMethoxyethyl)-4-Methyl-N-(thiophen-3-ylMethyl)benzenesulfonaMide is used as an intermediate in the synthesis of 5-[1-(2-Chlorophenyl)-2-methoxy-2-oxoethyl]thieno[3,2-c]pyridinium Bromide (C378370), a thieno[3,2-c]pyridinium compound with potent antimicrobial activity. N-(2,2-DiMethoxyethyl)-4-Methyl-N-(thiophen-3-ylMethyl)benzenesulfonaMide is particularly effective against a wide range of bacteria, making it a valuable asset in the development of new antibiotics and antimicrobial agents to combat drug-resistant infections.
Used in Chemical Research:
In addition to its applications in the pharmaceutical industry, N-(2,2-DiMethoxyethyl)-4-Methyl-N-(thiophen-3-ylMethyl)benzenesulfonaMide can also be utilized in chemical research for the development of new compounds with potential applications in various fields. Its unique molecular structure allows for further functionalization and modification, enabling the creation of novel molecules with diverse properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 58754-96-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,7,5 and 4 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 58754-96:
(7*5)+(6*8)+(5*7)+(4*5)+(3*4)+(2*9)+(1*6)=174
174 % 10 = 4
So 58754-96-4 is a valid CAS Registry Number.
58754-96-4Relevant articles and documents
Rho-kinase inhibitors
-
Page/Page column 76, (2010/02/05)
Disclosed are compounds and derivatives thereof, their synthesis, and their use as Rho-kinase inhibitors. These compounds of the present invention are useful for inhibiting tumor growth, treating erectile dysfunction, and treating other indications mediated by Rho-kinase, e.g., coronary heart disease.
